Makary says he wants nimbler FDA, calls for new drug pathways and pilots

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesCBERCDERLeadershipNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUS Food and Drug Administration (FDA)